Why Do So Few PharmDs Reach Executive Roles in Pharma?
Why aren’t more PharmD professionals in executive, corporate, or C-suite roles across the pharmaceutical industry?
Pharmacists bring a deep understanding of clinical medicine, patient outcomes, healthcare systems, reimbursement, formulary strategy, safety, and increasingly areas like market access, HEOR, medical affairs, and commercialization. On paper, that seems like a strong foundation for leadership.
Yet when you look at many senior leadership teams across companies like Pfizer, Novartis, Merck, or Johnson & Johnson, you often see MDs, MBAs, PhDs, finance professionals, or commercial leaders... but fewer PharmDs at the very top.
Why do you think that is?
Is it:
• Not enough PharmDs taking risks outside traditional pharmacy roles?
• Corporate bias toward other backgrounds?
• Or simply a pipeline issue, where PharmDs are only now entering these spaces in larger numbers?
For those already in pharma leadership, I’d genuinely love your perspective.
What do PharmDs need to do differently if they want to move from specialist roles into Director, VP, or executive leadership?